HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹27 Cr | ₹19 Cr | ₹27 Cr | ₹39 Cr | ₹34 Cr |
What is the latest Consolidated Net Profit of HESTER BIOSCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹39 Cr |
| Mar2021 | ₹34 Cr |
How is Consolidated Net Profit of HESTER BIOSCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹27 Cr | 45.52 | |
| Mar2024 | ₹19 Cr | -29.06 | |
| Mar2023 | ₹27 Cr | -32.28 | |
| Mar2022 | ₹39 Cr | 14.20 | |
| Mar2021 | ₹34 Cr | - | |
Compare Consolidated Net Profit of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,281.8 Cr | -2.3% | -3.5% | -34.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -2.3% |
-3.5% |
-34.1% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses